Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daptomycin vs Vancomycin in MRSA Diabetic Foot
NCT01199783Phase 3Terminated
- Sponsor
- Ruhr University Bochum
- Start
- Jul 2011
- Primary completion
- Oct 2013
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daptomycin in diabetic foot infection (DFI), sponsored by Ruhr University Bochum. Started Jul 2011; status: terminated.
02
Drugs
daptomycin
03
Conditions
diabetic foot infection (DFI)
Beyond the preview
Go deeper on NCT01199783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01199783.